肌钙蛋白I
介电谱
生物标志物
生物传感器
检出限
电阻抗
限制
纳米技术
宽动态范围
灵敏度(控制系统)
化学
电化学气体传感器
材料科学
电化学
动态范围
线性范围
计算机科学
生物医学工程
肌钙蛋白
肌钙蛋白复合物
肌钙蛋白C
分析灵敏度
作者
Mayank Garg,Heng Guo,Myeong Namkoong,Elizabeth Zhanov,Connor Malone,Md Saifur Rahman,Ayse Akcan‐Arikan,Limei Tian
标识
DOI:10.1016/j.bios.2026.118519
摘要
Cardiac troponin I (cTnI) is the gold-standard biomarker for acute myocardial infarction, yet current laboratory-based high-sensitivity assays require centralized infrastructure, trained personnel, and serial testing, limiting their suitability for real-time or continuous monitoring in resource-limited settings. Point-of-care electrochemical sensors have shown promise for rapid cTnI detection, but their reliance on antibodies as biorecognition elements and redox mediator solutions, and single-use operation restricts practical translation. Here, we report an ultrasound-enabled refreshable electrochemical biosensor for sensitive, stable, and repeatable cTnI monitoring. The device employs a cTnI-specific peptide as the biorecognition element, providing enhanced stability during storage, transport, and operation. Label-free electrochemical impedance spectroscopy quantifies impedance changes upon cTnI binding in body fluids, including serum and saliva, enabling rapid analysis and high sensitivity with electroosmotic enhancement. The sensor achieves a wide dynamic range from 0.031 pg/mL to 1.5 ng/mL for cTnI detection and quantification in 15 min. Compared to previously reported electrochemical platforms and conventional laboratory-based high-sensitivity assays, the proposed sensor offers improved analytical performance, as defined by limit of detection, dynamic range, and assay time. Importantly, low-power ultrasound effectively refreshes the sensor by removing bound targets without damaging the peptide, enabling sustained measurements and prolonging sensor lifetime. The demonstrated sensitivity enhancement and refreshability establish a foundation for extending this approach to diverse biomarkers, paving the way for frequent molecular monitoring and early clinical intervention.
科研通智能强力驱动
Strongly Powered by AbleSci AI